FindTrial
Sign In

Analysis of pregnancy outcome of Afar calciferol treating vitamin D deficienct and insufficienct women in vitro fertilization and embryo transfer (IVF) .

Analysis of pregnancy outcome of Afar calciferol treating vitamin D deficienct and insufficienct women in vitro fertilization and embryo transfer (IVF) .

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008188
Enrollment
Unknown
Registered
2016-03-30
Start date
2016-04-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitamin D deficienct and insufficienct women in vitro fertilization and embryo transfer (IVF)

Interventions

control group:The placebo
treat group:Afar calciferol

Sponsors

Nanjing General Hospital of Nanjing Military Command
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 39 Years

Inclusion criteria

Inclusion criteria: The inclusion criteria:vitamin D deficienct and insufficienct(Serum vitamin D levels were <30ng/ml) women in vitro fertilization and embryo transfer (IVF), acceptance of the standard long protocol, (Follicular stimulating hormone) FSH<10(IU/L), and aged between 20 and 39 years.

Exclusion criteria

Exclusion criteria: The exclusion criteria were liver,kidney, or heart disease;a severe male factor; endometriosis;Cushings syndrome; hyper or hypothyroidism; hyperprolactinemia;or a body mass index of more than 29 kg/m2 or less than 18 kg/m2.

Design outcomes

Primary

MeasureTime frame
the clinical pregnancy;Number of retrieved oocytes;good quality of embryos;the fertilization rate;the implantation rate;the abortion rate;—

Countries

China

Contacts

Public ContactLI CHEN

Nanjing General Hospital of Nanjing Military Command

872276095@qq.com+86 13851828017

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026